CPHARM - CRC Study

NCT07714291 | Not Yet Recruiting

• 1 other identifier: 53176
• Study Type: interventional
• Target: 316
• Locations: 1 country
• Sites: 1

Brief Summary

Colorectal cancer is one of the most common cancers in Malaysia and worldwide. Although it can often be prevented or treated successfully when detected early, many people in Malaysia are diagnosed at an advanced stage. Screening tests, such as the immunochemical faecal occult blood test (iFOBT), can help detect early signs of colorectal cancer; however, participation in screening remains low. Community pharmacies are easily accessible healthcare settings where people frequently seek health advice. Pharmacists may play an important role in improving awareness and encouraging colorectal cancer screening by providing education and support. However, more information is needed to understand how people perceive and respond to pharmacy-based colorectal cancer screening.

Conditions

Colorectal Cancer

Outcome Measures

Primary Outcomes (1)

• Beliefs and perceptions toward colorectal cancer and iFOBT screening

  Beliefs and perceptions toward colorectal cancer and iFOBT screening, measured using the Champion Health Belief Model Scale - Colorectal Cancer - Malay (CHBMS-CRC-M) subscales of perceived susceptibility, perceived benefits, and perceived barriers, between customers from pharmacies with and without the one-day awareness campaign. Each item is rated on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree). Domain scores will be calculated by summing (or averaging) the items within each domain, with higher scores indicating greater perceived susceptibility, benefits or barriers.

  From enrollment to the 8th week follow-up.

Secondary Outcomes (1)

• Proportion of participants who were willing to accept and perform iFOBT, report iFOBT results, and follow-up if needed.

  From enrollment to the 8th week of follow-up

Study Arms (2)

Pharmacy customers with campaign

EXPERIMENTAL

Campaign Components The one-day Ribbon of Hope campaign will be implemented at each intervention pharmacy to promote colorectal cancer awareness and screening uptake. The campaign consists of educational materials and one-on-one education about colorectal cancer.

Behavioral: Health awareness campaign

Pharmacy customers without campaign

NO INTERVENTION

Customers will receive standard pharmacy services such as medication dispensing and general health advice, but no educational materials or one-on-one education on CRC will be provided.

Interventions

Health awareness campaign BEHAVIORAL

Campaign Components The one-day Ribbon of Hope campaign will be implemented at each intervention pharmacy to promote colorectal cancer awareness and screening uptake. The campaign consists of educational materials and one-on-one education about colorectal cancer.

Pharmacy customers with campaign

Eligibility Criteria

• Age: 50 Years - 75 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adults aged 50 to 75 years
• Visiting participating community pharmacies during the study period
• Able to provide informed consent
• Willing to complete the study questionnaire
• Willing to provide consent for follow-up assessment of: iFOBT provision, iFOBT testing completion, iFOBT results

You may not qualify if:

• Previous diagnosis of colorectal cancer
• History of colonoscopy within the recommended screening interval (within past 1 year)
• Currently experiencing symptoms suggestive of colorectal cancer
• Having a first-degree relative diagnosed with colorectal cancer

Sponsors & Collaborators

• Monash University Malaysia: lead

Study Sites (1)

Big Caring Group

Klang, Selangor, 41050, Malaysia

Location

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal Neoplasms; Gastrointestinal Neoplasms; Digestive System Neoplasms; Neoplasms by Site; Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Colonic Diseases; Intestinal Diseases; Rectal Diseases

Central Study Contacts

Yen Jun Wong

CONTACT

60355146286; yenjun.wong@monash.edu

Chee Tao Chang

CONTACT

davidcct.crc@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 15, 2026
• First Posted: July 20, 2026
• Study Start (Estimated): November 1, 2026
• Primary Completion (Estimated): January 1, 2027
• Study Completion (Estimated): January 1, 2027
• Last Updated: July 21, 2026

Record last verified: 2026-07

Locations

MY (1)